Irvine, Calif., July 14, 2010 The Institute for Clinical & Translational Science at UC Irvine will get $20 million over five years from the National Institutes of Health to speed the transformation of scientific discoveries into medical advances for patients.
UCI is the first medical research institution in Orange County and the eighth statewide to receive the competitive Clinical & Translational Science Award. It enters a prestigious national consortium of CTSA beneficiaries whose membership will be capped at 60 by 2012. The NIH announced nine awardees today.
The sixth-largest grant in UCI history, the CTSA will foster multidisciplinary research involving the community in a wide range of fields such as genetics, diabetes, gerontology, pediatrics, cancer and infectious diseases while funding efforts to overcome impediments to biomedical innovation.
"With this award, UCI joins a select group of institutions supported by NIH to forge a new direction for clinical research in the U.S. for a generation to come," said Dr. Dan Cooper, ICTS director and primary CTSA investigator. "The grant will jump-start our endeavors to build effective multidisciplinary research teams to tackle important health issues, and it will bolster efforts to involve our community in the excitement of clinical discovery as partners."
Specifically, he said, the CTSA will support:
|Contact: Tom Vasich|
University of California - Irvine